Merck & Co.

1
Public Policy Statement | November 2023
European Union
Health Technology
Assessment Regulation

Merck welcomes the European Union’s Health Technology Assessment (EU HTA)
Regulation that should have solid Member State commitment to reduce demand for
duplication of clinical relative effectiveness assessments at the national level. Merck
supports the practice that Member States use the joint clinical assessment report to aid
understanding of the clinical value of the health technology....